Drug discovery, gene editing, and where biology meets computing.
7 stories tracked
Xavier Martinez / Wall Street Journal ·
No drug designed by artificial intelligence has won FDA clearance, and pharma leaders say biology is the obstacle
Anthropic ·
There are many opportunities to speed up drug development, even beyond the most commonly discussed applications of AI, like proposing initial designs for new molecules.
Rebecca Torrence / Bloomberg ·
Kevin Weil, the former OpenAI executive who led the ChatGPT maker's AI-for-science efforts, is launching a new startup aimed …
Madison Mills / Axios ·
OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios.
Robert Hart / The Verge ·
It took nearly 1,000 Claude agents 21 hours and 210 million tokens to uncover the 'novel enzyme system.'
Dealroom.co ·
What's the deal? Faro has raised a $37 million Series B round to develop AI tools aimed at speeding up clinical trials.
Cailey Gleeson / Fierce Healthcare ·
series B funding funding round Artificial Intelligence